These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9699081)

  • 1. Gastric retentive drug-delivery systems.
    Hwang SJ; Park H; Park K
    Crit Rev Ther Drug Carrier Syst; 1998; 15(3):243-84. PubMed ID: 9699081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
    Bardonnet PL; Faivre V; Pugh WJ; Piffaretti JC; Falson F
    J Control Release; 2006 Mar; 111(1-2):1-18. PubMed ID: 16403588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.
    Pawar VK; Kansal S; Garg G; Awasthi R; Singodia D; Kulkarni GT
    Drug Deliv; 2011 Feb; 18(2):97-110. PubMed ID: 20958237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro evaluation of floating rosiglitazone maleate microspheres.
    Rao MR; Borate SG; Thanki KC; Ranpise AA; Parikh GN
    Drug Dev Ind Pharm; 2009 Jul; 35(7):834-42. PubMed ID: 19337874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms.
    Read NW; Sugden K
    Crit Rev Ther Drug Carrier Syst; 1988; 4(3):221-63. PubMed ID: 3276406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific drug delivery in the gastrointestinal tract.
    Wilding I
    Crit Rev Ther Drug Carrier Syst; 2000; 17(6):557-620. PubMed ID: 11204736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in gastro retentive drug-delivery systems.
    Prinderre P; Sauzet C; Fuxen C
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1189-203. PubMed ID: 21671821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroretentive dosage forms].
    Kiss D; Zelkó R
    Acta Pharm Hung; 2005; 75(3):169-76. PubMed ID: 16318241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral controlled release dosage forms].
    Mehuys E; Vervaet C
    J Pharm Belg; 2010 Jun; (2):34-8. PubMed ID: 20623984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile drug-delivery systems.
    Bussemer T; Otto I; Bodmeier R
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):433-58. PubMed ID: 11763497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on gastroretentive drug delivery systems for improving drug bioavailability.
    Lopes CM; Bettencourt C; Rossi A; Buttini F; Barata P
    Int J Pharm; 2016 Aug; 510(1):144-58. PubMed ID: 27173823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of drugs to the gastrointestinal tract.
    Lavelle EC
    Crit Rev Ther Drug Carrier Syst; 2001; 18(4):341-86. PubMed ID: 11605896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hollow microspheres of diclofenac sodium - a gastroretentive controlled delivery system.
    Bv B; R D; S B; Abraham S; Furtado S; V M
    Pak J Pharm Sci; 2008 Oct; 21(4):451-4. PubMed ID: 18930869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric retentive dosage forms: a review.
    Hou SY; Cowles VE; Berner B
    Crit Rev Ther Drug Carrier Syst; 2003; 20(6):459-97. PubMed ID: 14979868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances.
    Sangalli ME; Maroni A; Foppoli A; Zema L; Giordano F; Gazzaniga A
    Eur J Pharm Sci; 2004 Aug; 22(5):469-76. PubMed ID: 15265517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.